Posted by admin on May 21st, 2022

Wall Street analysts forecast that DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) will post earnings of $0.56 per share for the current quarter, according to Zacks Investment Research. Eight analysts have provided estimates for DENTSPLY SIRONA’s earnings. The lowest EPS estimate is $0.49 and the highest is $0.65. DENTSPLY SIRONA posted earnings of $0.71 per share during the same quarter last year, which would suggest a negative year-over-year growth rate of 21.1%. The business is expected to issue its next quarterly earnings report on Monday, January 1st.

According to Zacks, analysts expect that DENTSPLY SIRONA will report full-year earnings of $2.44 per share for the current year, with EPS estimates ranging from $2.37 to $2.62. For the next financial year, analysts expect that the business will report earnings of $2.66 per share, with EPS estimates ranging from $2.55 to $2.75. Zacks Investment Research’s earnings per share averages are an average based on a survey of research firms that cover DENTSPLY SIRONA.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last announced its quarterly earnings results on Tuesday, May 10th. The medical instruments supplier reported $0.52 EPS for the quarter, missing the consensus estimate of $0.56 by ($0.04). DENTSPLY SIRONA had a net margin of 8.81% and a return on equity of 11.63%. The firm had revenue of $9.67 billion during the quarter, compared to analyst estimates of $982.05 million. During the same quarter in the previous year, the business posted $0.72 EPS. DENTSPLY SIRONA’s revenue for the quarter was up 841.1% compared to the same quarter last year.

A number of research firms recently commented on XRAY. Robert W. Baird lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “neutral” rating and lowered their price objective for the company from $67.00 to $48.00 in a research note on Tuesday, April 19th. William Blair lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Tuesday, April 19th. Barrington Research lowered their price objective on shares of DENTSPLY SIRONA from $53.00 to $51.00 in a research note on Wednesday, May 11th. Bank of America lowered shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $66.00 to $49.00 in a research report on Tuesday, April 19th. Finally, Piper Sandler restated a “neutral” rating and issued a $46.00 price target (down previously from $71.00) on shares of DENTSPLY SIRONA in a research report on Wednesday, April 20th. Six analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Hold” and an average price target of $52.89.

Shares of NASDAQ:XRAY traded up $0.43 during trading hours on Friday, hitting $37.75. The stock had a trading volume of 1,618,060 shares, compared to its average volume of 2,696,295. The stock’s fifty day simple moving average is $44.51 and its 200 day simple moving average is $50.53. DENTSPLY SIRONA has a 1-year low of $35.00 and a 1-year high of $68.82. The firm has a market capitalization of $8.13 billion, a price-to-earnings ratio of 22.34 and a beta of 0.94. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.03 and a current ratio of 1.45.

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 8th. Investors of record on Friday, March 25th were paid a $0.125 dividend. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.11. The ex-dividend date of this dividend was Thursday, March 24th. This represents a $0.50 dividend on an annualized basis and a yield of 1.32%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently 29.59%.

In related news, Director Eric Brandt sold 6,900 shares of the firm’s stock in a transaction that occurred on Tuesday, May 3rd. The shares were sold at an average price of $39.71, for a total value of $273,999.00. Following the completion of the transaction, the director now owns 35,155 shares of the company’s stock, valued at approximately $1,396,005.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.76% of the company’s stock.

Several large investors have recently modified their holdings of XRAY. Optimal Asset Management Inc. increased its holdings in shares of DENTSPLY SIRONA by 0.3% during the 3rd quarter. Optimal Asset Management Inc. now owns 68,883 shares of the medical instruments supplier’s stock valued at $3,999,000 after acquiring an additional 186 shares during the last quarter. State of Michigan Retirement System increased its holdings in shares of DENTSPLY SIRONA by 0.4% during the 4th quarter. State of Michigan Retirement System now owns 55,049 shares of the medical instruments supplier’s stock valued at $3,071,000 after acquiring an additional 200 shares during the last quarter. Mutual of America Capital Management LLC increased its holdings in shares of DENTSPLY SIRONA by 0.7% during the 4th quarter. Mutual of America Capital Management LLC now owns 28,920 shares of the medical instruments supplier’s stock valued at $1,613,000 after acquiring an additional 201 shares during the last quarter. Signaturefd LLC grew its holdings in DENTSPLY SIRONA by 13.0% in the 4th quarter. Signaturefd LLC now owns 1,786 shares of the medical instruments supplier’s stock valued at $100,000 after buying an additional 205 shares during the last quarter. Finally, Headinvest LLC grew its holdings in DENTSPLY SIRONA by 0.4% in the 3rd quarter. Headinvest LLC now owns 61,365 shares of the medical instruments supplier’s stock valued at $3,562,000 after buying an additional 216 shares during the last quarter. 94.79% of the stock is owned by institutional investors.

DENTSPLY SIRONA Company Profile (Get Rating)

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.

Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Raymond James Reiterates “Buy” Rating for Palo Alto Networks (NASDAQ:PANW)

Hippo (HIPO) and Its Peers Head-To-Head Contrast